Necessity of heparin for maintaining peripheral venous catheters: A systematic review and meta-analysis.

Heparin has typically been used as a flushing or infusion solution for vascular lines in daily practice. However, several clinical trials have yielded controversial results about the benefits of heparin in maintaining peripheral venous catheters. The present meta-analysis was conducted to evaluate the efficacy of heparin on the patency profiles and complications in peripheral intravenous catheters. PubMed, Embase and Cochrane Central Register of Controlled Trials were searched up to February 2016 for randomized controlled trials comparing heparin with placebo in maintaining peripheral intravenous catheters. Additional studies were retrieved from the reference lists of identified articles. In total 32 eligible studies were included, from which the pooled standard mean difference (SMD), relative risk (RR) and corresponding 95% confidence interval (CI) were calculated. The use of heparin as a continuous infusion significantly prolonged the duration of patency (SMD, 0.90; 95% CI, 0.48-1.32; P<0.001), reduced rates of infusion failure (RR, 0.83; 95% CI, 0.76-0.92; P<0.001) and occlusion (RR, 0.82; 95% CI, 0.69-0.98; P<0.05) in a peripheral intravenous catheter. However, there were no significant changes in the duration of patency and infusion failure when heparin was used intermittently as a flushing solution, although a significantly decreased risk of occlusion was observed in this setting (RR, 0.80; 95% CI, 0.66-0.98; P<0.05). Furthermore, the risk of phlebitis was significantly decreased by both continuous infusion (RR, 0.66; 95% CI, 0.58-0.75; P<0.01) and intermittent flushing (RR, 0.70; 95% CI, 0.56-0.86; P<0.01) of heparin in peripheral venous catheters. In conclusion, the use of heparin as continuous infusion in peripheral intravenous catheters improved the duration of patency, reduced infusion failure and phlebitis, whereas heparin as intermittent flushing showed more benefits in ameliorating phlebitis rather than in patency profiles.

[1]  Xin-Zu Chen,et al.  Heparin Saline Versus Normal Saline for Flushing and Locking Peripheral Venous Catheters in Decompensated Liver Cirrhosis Patients , 2015, Medicine.

[2]  V. Sreenivas,et al.  Heparin for prolonging peripheral intravenous catheter use in neonates: a randomized controlled trial , 2014, Journal of Perinatology.

[3]  Amanda Burls,et al.  Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults. , 2014, The Cochrane database of systematic reviews.

[4]  S. Robertson-Malt,et al.  Heparin versus normal saline for patency of arterial lines. , 2014, The Cochrane database of systematic reviews.

[5]  M. Kumar,et al.  Low-dose heparin for prolonging the patency of peripheral intravenous catheters in adults: A Systematic review and Meta-analysis , 2014 .

[6]  R. Hayes,et al.  A man with acute venous thromboembolism and thrombocytopenia , 2014, BMJ : British Medical Journal.

[7]  V. Midha,et al.  Comparative Efficacy of Heparin Saline and Normal Saline Flush for Maintaining Patency of Peripheral Intravenous Lines: A Randomized Control Trial. - , 2014 .

[8]  B. Vandermeer,et al.  Low-Dose Heparin Use and the Patency of Peripheral IV Catheters in Children: A Systematic Review , 2013, Pediatrics.

[9]  I. Cetin,et al.  Heparin infusion to prevent umbilical venous catheter related thrombosis in neonates. , 2012, Thrombosis research.

[10]  C. Tinelli,et al.  Intermittent flushing with heparin versus saline for maintenance of peripheral intravenous catheters in a medical department: a pragmatic cluster-randomized controlled study. , 2012, Worldviews on evidence-based nursing.

[11]  J. Weitz,et al.  Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo. , 2011, Blood.

[12]  G. J. van der Wilt,et al.  Effectiveness of heparin solution versus normal saline in maintaining patency of intravenous locks in neonates: a double blind randomized controlled study. , 2011, Journal of advanced nursing.

[13]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[14]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[15]  H. Schäfers,et al.  Delayed-type heparin allergy: diagnostic procedures and treatment alternatives--a case series including 15 patients , 2008, The World Allergy Organization journal.

[16]  R. Powell,et al.  Heparin induced thrombocytopenia: diagnosis and management update , 2007, Postgraduate Medical Journal.

[17]  M. Chan,et al.  A randomized controlled trial for maintaining peripheral intravenous lock in children. , 2007, International journal of nursing practice.

[18]  I. Bates,et al.  The efficacy of heparin in maintaining peripheral infusions in neonates , 1995, European Journal of Pediatrics.

[19]  A. Greinacher,et al.  Benefit and risk of heparin for maintaining peripheral venous catheters in neonates: a placebo-controlled trial. , 2003, The Journal of pediatrics.

[20]  D. Harris,et al.  The effects of heparin versus normal saline for maintenance of peripheral intravenous locks in pregnant women. , 2003, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN.

[21]  A. Schultz,et al.  Comparison of normal saline and heparinized saline for patency of IV locks in neonates. , 2002, Applied nursing research : ANR.

[22]  M. Binder,et al.  [Treatment of superficial thrombophlebitis]. , 2002, Hamostaseologie.

[23]  C. Leroux-Robert,et al.  Risk of heparin lock-related bleeding when using indwelling venous catheter in haemodialysis. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  V. Shah,et al.  Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. , 2001, Cochrane Database of Systematic Reviews.

[25]  C. Folwaczny,et al.  Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease , 1999, American Journal of Gastroenterology.

[26]  D. McMillan,et al.  Heparin is not required for peripheral intravenous locks in neonates. , 1999, Paediatrics & child health.

[27]  K. Holme,et al.  Heparin in inflammation: potential therapeutic applications beyond anticoagulation. , 1999, Advances in pharmacology.

[28]  C. Kleiber,et al.  A randomized trial of heparin and saline for maintaining intravenous locks in neonates. , 1998, Journal of the Society of Pediatric Nurses : JSPN.

[29]  D. Cook,et al.  Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials , 1998, British medical journal.

[30]  T. Nelson,et al.  0.9% sodium chloride injection with and without heparin for maintaining peripheral indwelling intermittent-infusion devices in infants. , 1998, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[31]  K. LeDuc.  Efficacy of normal saline solution versus heparin solution for maintaining patency of peripheral intravenous catheters in children. , 1997, Journal of emergency nursing: JEN : official publication of the Emergency Department Nurses Association.

[32]  Kotter Rw.  Heparin vs saline for intermittent intravenous device maintenance in neonates. , 1996 .

[33]  P. Beecroft,et al.  Intravenous lock patency in children: Dilute heparin versus saline , 1996 .

[34]  R. Kotter.  Heparin vs saline for intermittent intravenous device maintenance in neonates. , 1996, Neonatal network : NN.

[35]  J. Thorp,et al.  Heparin versus normal saline as a peripheral line flush in maintenance of intermittent intravenous lines in obstetric patients , 1995, Obstetrics and gynecology.

[36]  J. Hecker,et al.  Effects of low-dose heparin on failure of intravenous infusions in children. , 1995, Heart & lung : the journal of critical care.

[37]  K. Hanrahan,et al.  Heparin vs. saline for peripheral i.v. locks in children. , 1993, Pediatric nursing.

[38]  I. Fioravanti,et al.  Heparinized Saline Or Normal Saline: As a Flush Solution in Intermittent Intravenous lines In Infants and Children , 1993, MCN. The American journal of maternal child nursing.

[39]  J. Shoaf,et al.  Efficacy of normal saline injection with and without heparin for maintaining intermittent intravenous site. , 1992, Applied nursing research : ANR.

[40]  K. Kirchhoff,et al.  Analysis of the research about heparinized versus nonheparinized intravascular lines. , 1991, Heart & lung : the journal of critical care.

[41]  D. Ones,et al.  A Meta‐Analysis of Effects of Heparin Flush and Saline Flush: Quality and Cost Implications , 1991, Nursing research.

[42]  I. Benjamin,et al.  Total parenteral nutrition via a peripheral vein: A comparison of heparinised and non‐heparinised regimens , 1991 .

[43]  V. Gibson,et al.  Effects of heparin versus saline solution on intermittent infusion device irrigation. , 1990, Heart & lung : the journal of critical care.

[44]  R. Hamilton,et al.  Heparin sodium versus 0.9% sodium chloride injection for maintaining patency of indwelling intermittent infusion devices. , 1988, Clinical pharmacy.

[45]  M. Cohen,et al.  Hickman catheter clots: a common occurrence despite daily heparin flushing. , 1987, Cancer treatment reports.

[46]  X. Leverve,et al.  Peripheral venous complications of a hyperosmolar (960 mOsm) nutritive mixture: The effect of heparin and hydrocortisone. A multicenter double-blinded random study in 98 patients. , 1986, Clinical nutrition.

[47]  C. Springer,et al.  Heparinization of alimentation solutions administered through peripheral veins in premature infants: a controlled study. , 1984, Pediatrics.

[48]  M. Bassan,et al.  Prevention of lidocaine-infusion phlebitis by heparin and hydrocortisone. , 1983, Chest.

[49]  T. Hennessy,et al.  The influence of heparin on intravenous infusions: A prospective study , 1980, The British journal of surgery.

[50]  H. Daniell.  Heparin in the prevention of infusion phlebitis. A double-blind controlled study. , 1973, JAMA.

[51]  M. Sketch,et al.  Use of percutaneously inserted venous catheters in coronary care units. , 1972, Chest.

[52]  H. Daniell.  Heparin prevention of catheter thrombosis. , 1971, JAMA.